{"denomUnitsSelected":"Participants","description":"Will be analyzed using Kaplan-Meier methodology.","reportingStatus":"NOT_POSTED","timeFrame":"Time between each patient's best tumor response and progression>>> (or date of last disease assessment for patients who die without progression or are lost to follow-up), assessed up to 2 years","title":"Duration of Response in Crossover Patients (Phase II)","type":"OTHER_PRE_SPECIFIED"}